1. ALLA AKTIER
  2. NYHETER
  3. NEOLA MEDICAL

Neola Medical

Nyheter Neola Medical Nyheter alla bolag

Neola Medical Showcases GASMAS Technology at Prestigious Neonatal Medicine Congress with Lecture by Leading U.S. Professor in Neonatology

Neola Medical (publ) is pleased to announce its prominent role at the upcoming Xth RECENT ADVANCES IN NEONATAL MEDICINE Congress, held from October 12-14 in Wurzburg, Germany. As one of the largest and most prestigious scientific gatherings outside the U.S., this congress brings together the world’s foremost experts in neonatal care. Neola Medical is proud to sponsor a special lecture on its GASMAS technology, which will be delivered by the esteemed MD DM Professor Vineet Bhandari, Division Head in Neonatology at The Children’s Regional Hospital at Cooper, Camden, USA. Professor Bhandari’s lecture, titled “GASMAS transit to the NICU – are we there yet?”, will offer an in-depth exploration of the transformative potential of the GASMAS technology used in Neola Medical’s continuous lung monitoring device for preterm born babies.

“Technology innovation that may improve the clinical outcome of preterm born babies is of highest interest to neonatologists around the world. GASMAS appears to be safe, and if shown to be accurate and reliable, it may improve our knowledge of alveolar oxygen concentration and content and its changes during postnatal transition and in diverse neonatal lung conditions, including respiratory distress syndrome, BPD, pneu- mothorax, pneumonia, atelectasis, and pulmonary edema, among others. Future clinical studies can then determine the cost effectiveness and utility of GASMAS in improving neonatal outcomes. The potential of GASMAS technology in modern neonatal care is an exciting step forward in neonatal medicine, and I look forward to sharing its potential future with healthcare professionals from around the world.”, says Professor Vineet Bhandari

“We are honored that Professor Bhandari, who is one of the most prominent leaders within Neonatology in the world, will share the clinical learnings and potential with using GASMAS technology in modern neonatal care in this esteemed academic forum, with the aim of improving clinical outcomes for preterm born babies.”, says CEO Hanna Sjöström

For more information about Neola Medical’s participation in the Xth RECENT ADVANCES IN NEONATAL MEDICINE congress, please visit https://www.recent-advances.com

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical Showcases GASMAS Technology at Prestigious Neonatal Medicine Congress with Lecture by Leading U.S. Professor in Neonatology

Datum 2024-09-18, kl 07:00
Källa MFN
Bifogade filer
Neola Medical Showcases GASMAS Technology at Prestigious Neonatal Medicine Congress with Lecture by Leading U.S. Professor in Neonatology
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!